Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Overexpression of Nucleolin and Associated Genes in Prostate Cancer

19 Apr 2022

Abstract excerpt

Prostate cancer (PCa) is the second most frequent cancer and the fifth leading cause of cancer death in men worldwide. If local PCa presents a favorable prognosis, available treatments for advanced PCa display limiting benefits due to therapeutic resistances. Nucleolin (NCL) is a ubiquitous protein involved in numerous cell processes, such as ribosome biogenesis, cell cycles, or angiogenesis. NCL is overexpressed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Prostate Cancer Treatment and Research
Share to RNA Research and Splicing
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35562881
DOI: 10.3390/ijms23094491

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Overexpression of Nucleolin and Associated Genes in Prostate CancerPMID 35562881Read ↗

Importance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of prostate cancerSemantic proximity Read ↗

Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?Semantic proximity Read ↗

Prostate cancer-associated lncRNAs.Semantic proximity Read ↗

Long non-coding RNAs and prostate cancer.Semantic proximity Read ↗

Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancerSemantic proximity Read ↗

The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease managementSemantic proximity Read ↗

Discovery and characterization of long intergenic non-coding RNAs (lincRNA) module biomarkers in prostate cancer: an integrative analysis of RNA-Seq data.Semantic proximity Read ↗

Characterization and validation of long noncoding RNAs as new candidates in prostate cancerSemantic proximity Read ↗

Evaluation of NUF2 and GMNN Expression in Prostate Cancer: Potential Biomarkers for Prostate Cancer ScreeningSemantic proximity Read ↗

Elevated NPM1 and FBL expression correlates with prostate cancer aggressiveness and progressionSemantic proximity Read ↗

Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional StudiesSemantic proximity Read ↗

The lncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.